Patent details

EP1185268 Title: THE THERAPEUTIC USE OF D-THREO-METHYLPHENIDATE FOR THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER

Basic Information

Publication number:
EP1185268
PCT Application Number:
PCT/GB/2000/002234
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009405044
PCT Publication Number:
WO/2000/074680
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THE THERAPEUTIC USE OF D-THREO-METHYLPHENIDATE FOR THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
French Title of Invention:
UTILISATION THERAPEUTIQUE DE i D-THREO /i -METHYLPHENIDATE POUR LE TRAITEMENT DE TROUBLES D'HYPERACTIVITE DEFICITAIRES DE L'ATTENTION
German Title of Invention:
THERAPEUTISCHE VERWENDUNG VON D-THREO-METHYLPHENIDATE ZUR BEHANDLUNG VON AUFMERKSAMKEITSMANGEL-HYPERAKTIVITÄTSSTÖRUNGEN
SPC Number:

Dates

Filing date:
08/06/2000
Grant date:
17/08/2005
EP Publication Date:
17/08/2005
PCT Publication Date:
14/12/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/03/2002
EP B1 Publication Date:
17/08/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/06/2006
Expiration date:
08/06/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/06/2000
 
 

Name:
Celltech Pharma Europe Limited
Address:
208 Bath Road, Slough, Berkshire SL1 3WE, United Kingdom (GB)

Inventor

Name:
Davidson Elizabeth Janina, Celltech Pharma Ltd
Address:
United Kingdom (GB)

Priority

Priority Number:
9913458
Priority Date:
09/06/1999
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/4458;
Filing date Document type Number of pages